"Tumor Hypoxia" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Hypoxic conditions in tumor cells due to the tumor outgrowing its blood supply. It is associated with increased METASTASIS and resistance to RADIOTHERAPY and DRUG THERAPY.
| Descriptor ID |
D000072258
|
| MeSH Number(s) |
G03.197.300.500 G04.270.300.500
|
| Concept/Terms |
Tumor Hypoxia- Tumor Hypoxia
- Hypoxia, Tumor
- Hypoxias, Tumor
- Tumor Hypoxias
- Tumor Cell Hypoxia
- Cell Hypoxia, Tumor
- Cell Hypoxias, Tumor
- Hypoxia, Tumor Cell
- Hypoxias, Tumor Cell
- Tumor Cell Hypoxias
|
Below are MeSH descriptors whose meaning is more general than "Tumor Hypoxia".
Below are MeSH descriptors whose meaning is more specific than "Tumor Hypoxia".
This graph shows the total number of publications written about "Tumor Hypoxia" by people in this website by year, and whether "Tumor Hypoxia" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2016 | 1 | 0 | 1 |
| 2019 | 1 | 0 | 1 |
| 2020 | 1 | 0 | 1 |
| 2021 | 1 | 0 | 1 |
| 2024 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Tumor Hypoxia" by people in Profiles.
-
Comparison of Liquid with Particle Embolics in a Translational Rat Model of Hepatocellular Carcinoma: Histologic and Radiographic Responses. J Vasc Interv Radiol. 2025 04; 36(4):670-678.e2.
-
Protocol to detect and quantify tumor hypoxia in mice using photoacoustic imaging. STAR Protoc. 2024 06 21; 5(2):102993.
-
Hypoxia-Inducible Factor 2 Alpha (HIF2a) Inhibitors: Targeting Genetically Driven Tumor Hypoxia. Endocr Rev. 2023 03 04; 44(2):312-322.
-
Hypoxia enhances motility and EMT through the Na+/H+ exchanger NHE-1 in MDA-MB-231 breast cancer cells. Exp Cell Res. 2022 03 01; 412(1):113006.
-
Mechanisms of vasculogenic mimicry in hypoxic tumor microenvironments. Mol Cancer. 2021 01 04; 20(1):7.
-
Role of Mitochondria in Cancer Immune Evasion and Potential Therapeutic Approaches. Front Immunol. 2020; 11:573326.
-
Redox Dyshomeostasis Strategy for Hypoxic Tumor Therapy Based on DNAzyme-Loaded Electrophilic ZIFs. Angew Chem Int Ed Engl. 2020 12 07; 59(50):22537-22543.
-
Mechanism-Specific Pharmacodynamics of a Novel Complex-I Inhibitor Quantified by Imaging Reversal of Consumptive Hypoxia with [18F]FAZA PET In Vivo. Cells. 2019 11 21; 8(12).
-
Characterization of Hypoxia-associated Molecular Features to Aid Hypoxia-Targeted Therapy. Nat Metab. 2019 04; 1(4):431-444.
-
Hypoxia-Associated Factor (HAF) Mediates Neurofibromin Ubiquitination and Degradation Leading to Ras-ERK Pathway Activation in Hypoxia. Mol Cancer Res. 2019 05; 17(5):1220-1232.